Patents/Assignees

Takeda Pharmaceutical Company Limited

256 patents in portfolio

US12528802utility2026
Heterocyclic Compound
0 cites
US12503501utility2025
Treatment of Central Nervous System Disorders by Intranasal Administration of Immunoglobulin G
0 cites
US12493047utility2025
Cleaved High Molecule Weight Kininogen (HMWK) Antibodies and Methods of Using
0 cites
US12492390utility2025
Methods of Purifying Recombinant ADAMTS13 and Other Proteins and Compositions Thereof
0 cites
USD1103202design2025
Display Screen or Portion Thereof with Graphical User Interface
0 cites
US12478673utility2025
Constrained Conditionally Activated Binding Proteins
0 cites
US12479791utility2025
Cationic Lipid
0 cites
US12479798utility2025
Method for Producing Pyrrolidine Compound
0 cites
USD1101762design2025
Display Screen with a Transitional Graphical User Interface
0 cites
US12460016utility2025
Plasma Kallikrein Binding Proteins
0 cites
US12454575utility2025
Nucleic Acids Encoding Fcrn-binding Antibodies, Pharmaceutical Compositions Thereof and Methods of Use Thereof to Make Antibodies
0 cites
US12447169utility2025
Maribavir Isomers, Compositions, Methods of Making and Methods of Using
0 cites
US12447170utility2025
Use of Maribavir in Treatment Regimens
0 cites
US12448377utility2025
Heterocyclic Compound
0 cites
USD1098151design2025
Display Screen with a Graphical User Interface
0 cites
USD1098171design2025
Display Screen or Portion Thereof with Graphical User Interface
0 cites
US12441724utility2025
Inhibitors of Plasma Kallikrein and Uses Thereof
0 cites
US12442824utility2025
Assays for Determining Plasma Kallikrein System Biomarkers
0 cites
US12433289utility2025
Compositions and Methods of Cryopreserving Cells
0 cites
US12433824utility2025
Packaging for Multiple Containers
0 cites

← PreviousPage 2 of 13Next →